Study guide

3.3 Impairment, the Utah Professionals Health Program & Reinstatement

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

3.3 Impairment, the Utah Professionals Health Program & Reinstatement

Key Takeaways Explain This Topic AI

Practicing while impaired by drugs or alcohol, or while physically or mentally unfit, is unprofessional conduct under Utah Code § 58-1-501(2)(a)(v)–(vi).

The Utah Professionals Health Program is a confidential alternative to public discipline for licensees, including pharmacists, who have substance use disorders (Utah Code § 58-4a-103).

A licensee may enter a UPHP program contract at any time before a hearing under § 63G-4-206 concludes, and a pending adjudicative proceeding is stayed while the licensee completes the contract.

If a court finds a pharmacist incapacitated or mentally ill and unable to practice safely, the director must immediately suspend the license without further administrative proceedings (Utah Code § 58-17b-701(2)).

A license suspended or revoked under § 58-1-401 generally may not be reinstated within 90 days, and the petitioner may be required to pass examinations (Utah Code §§ 58-1-403, 58-17b-506).

Last updated: September 2026

3.3 Impairment, the Utah Professionals Health Program & Reinstatement

The blueprint includes "reporting to and participating in programs addressing the inability to practice with reasonable skill and safety." Utah handles impairment in three ways: it defines impaired practice as unprofessional conduct, offers a confidential health program, and provides fast-track incapacity procedures.

Impairment as a disciplinary ground

Under § 58-1-501(2)(a)(v) , it is unprofessional conduct to use intoxicants, drugs, narcotics, or similar chemicals to the extent that the conduct does, or might reasonably be considered to, impair the ability to practice with reasonable skill and safety.

Practicing while physically or mentally unfit is unprofessional conduct under § 58-1-501(2)(a)(vi).

DOPL may deny, restrict, or otherwise act on a license when the licensee cannot practice with reasonable skill and safety because of an illness or condition that threatens public safety (§ 58-1-401(2)(d)).

Using a prescription drug or controlled substance not lawfully prescribed to you is unlawful conduct (§ 58-17b-501(13)). Controlled-substance violations are also unprofessional conduct (§ 58-17b-502(1)(g)).

The Utah Professionals Health Program (Title 58, Chapter 4a)

The Utah Professionals Health Program (UPHP) , created in 2020, is run by DOPL as "an alternative to public disciplinary action for licensees who have substance use disorders" (§ 58-4a-103). It covers licensees under several health-care practice acts, including the Pharmacy Practice Act (§ 58-4a-102). DOPL describes UPHP as a confidential program. It does not provide treatment itself. It coordinates assessment, treatment placement, and long-term aftercare monitoring.

Feature Rule

Who may enter A licensee with a substance use disorder, or one DOPL has referred for diagnostic monitoring (§ 58-4a-105(1)(b), (3))

When Any time before the conclusion of a hearing under § 63G-4-206. Self-referral before an investigation is not required.

Effect on a pending case If a program contract is signed after an adjudicative proceeding has started, the proceeding is stayed pending successful completion (§ 58-4a-106(2))

Admissions Facts stipulated in the program contract are binding admissions in any later proceeding to terminate the contract or in other DOPL discipline (§ 58-4a-106(1))

Other misconduct Entering UPHP does not stop DOPL from acting on other misconduct not covered by the contract (§ 58-4a-106(3))

Denial A program decision denying participation is final and cannot be appealed (§ 58-4a-105(5))

Violation DOPL may serve an order to show cause . The director then terminates the contract and places the licensee on probation , and for especially egregious misconduct may revoke the license (§ 58-4a-107)

Reporting Program contracts let DOPL report the licensee's progress to the licensing board, to the extent HIPAA permits (§ 58-4a-111)

Meetings Program meetings and hearings are not subject to the Open and Public Meetings Act (§ 58-4a-109)

UPHP has an executive advisory committee of nine members, chaired by the Commerce executive director or a designee, and a clinical advisory committee of addiction experts (§ 58-4a-104). Nothing in the chapter prevents DOPL from issuing an emergency order (§ 58-4a-108).

Incapacity procedures for pharmacists (§ 58-17b-701)

Court finding. If a court finds a pharmacist to be an incapacitated person , or finds that the pharmacist has a mental illness and cannot practice safely , the director must immediately suspend the license when the judgment is entered, without further proceedings, even if an appeal is pending. The director then notifies the pharmacist in writing.

Reasonable cause without a court finding. If DOPL and a majority of the board find reasonable cause to believe a pharmacist cannot practice with reasonable skill because of illness, excessive use of drugs or alcohol, or another condition, the board recommends that the director file a petition. A hearing is then held on that capacity question alone.

Consent to examination. By accepting a license, every pharmacist consents to an immediate mental or physical examination at the pharmacist's own expense when DOPL, with a majority of the board, directs it in writing on reasonable cause, and waives privilege for the examiner's reports.

Refusing the exam. Failing to submit to the exam is grounds for immediate suspension by written order of the director, unless the failure was beyond the pharmacist's control and unrelated to the illness.

Hearing. A pharmacist suspended under these provisions may request a hearing within 10 days after suspension, limited to whether the suspension should continue.

Restoration. The pharmacist may ask DOPL and the board, at reasonable intervals, to consider evidence of a changed condition and to restore the license in whole or in part.

Reinstatement after discipline

A license revoked, suspended, or surrendered may be the subject of a written petition for reinstatement "at reasonable intervals." After investigation and a hearing, DOPL may grant or deny it, and may require the person to pass examinations to re-enter practice (§ 58-17b-506).

A license may not be reinstated within 90 days after action under § 58-1-401, unless DOPL and the board impose other conditions (§ 58-1-403).

A petition during the term of a restriction, suspension, or probation is treated as a request to modify the order , not a new application (R156-1-308h). After the term ends, the applicant submits a full application, pays renewal and reinstatement fees, shows current competence, and pays any outstanding fines (R156-1-308i).

Practical scenario

A night-shift hospital pharmacist appears impaired and there are unexplained override removals of fentanyl from an automated dispensing cabinet. The PIC removes the pharmacist from patient care, secures the records, and reports the suspected diversion. Losses and thefts of controlled substances must be reported to DEA with a copy to DOPL, and to local law enforcement (R156-37-602(2); see Section 11.3). The pharmacist may still enter UPHP while DOPL's case is pending, and doing so would stay the adjudicative proceeding under the program contract. Any facts the pharmacist stipulates in the contract become binding admissions.